The journey from laboratory discovery to patient treatment for groundbreaking drugs is complex, with chemical intermediates forming the backbone of this process. One such crucial component is 2-Methoxy-4-(N-acetyl-piperazin-1-yl)aniline, a compound critical in the synthesis of CO-1686. This intermediate, recognized by CAS number 1021426-42-5, is essential for researchers and manufacturers in the pharmaceutical sector looking to produce advanced cancer therapies.

CO-1686 is a targeted covalent inhibitor that has shown promise in treating non-small cell lung cancer (NSCLC) with specific EGFR mutations. The development of such sophisticated drugs necessitates a reliable supply of high-quality chemical precursors. 2-Methoxy-4-(N-acetyl-piperazin-1-yl)aniline serves as a vital starting material, providing the necessary structural elements for the final therapeutic molecule. Its physical and chemical properties, including its appearance as a brown powder and an assay typically exceeding 98.0%, are key indicators of its suitability for pharmaceutical applications.

For R&D scientists and procurement managers, understanding the supply landscape for these specialized chemicals is paramount. When planning to purchase 2-Methoxy-4-(N-acetyl-piperazin-1-yl)aniline, identifying reputable chemical suppliers in China is often a strategic move. These manufacturers can offer competitive CO-1686 intermediate price points and ensure consistent availability, which are crucial for maintaining project timelines and budgets. Sourcing from a trusted 2-Methoxy-4-(N-acetyl-piperazin-1-yl)aniline manufacturer ensures that the material adheres to stringent quality standards.

The importance of accurate CAS identification, such as CAS 1021426-42-5 supplier searches, cannot be overstated. It allows for precise identification and sourcing of the correct chemical compound. Pharmaceutical companies need assurance that the intermediates they procure will perform as expected in complex multi-step syntheses, ultimately impacting the efficacy and safety of the final drug product.

In essence, 2-Methoxy-4-(N-acetyl-piperazin-1-yl)aniline is more than just a chemical compound; it's a critical enabler for advancing cancer treatment research. By collaborating with reliable Chinese suppliers and focusing on the quality and specifications of this key intermediate, pharmaceutical professionals can significantly contribute to the successful development and manufacturing of CO-1686 and similar life-saving medications.